Structures by: Hediger M. A.
Total: 8
31
C23H30F3N3O,2(C2F3O2)
RSC Medicinal Chemistry (2020)
a=8.23301(6)Å b=13.02347(14)Å c=13.57687(16)Å
α=98.1817(9)° β=92.5946(8)° γ=103.5389(8)°
19
C20H32N3O2,C2F3O2,1.65(H2O)
RSC Medicinal Chemistry (2020)
a=17.41370(10)Å b=8.14510(10)Å c=33.6364(2)Å
α=90° β=90.4130(10)° γ=90°
Cis-22a
C22H29N3
RSC Medicinal Chemistry (2020)
a=7.2232(3)Å b=8.9059(4)Å c=15.2815(6)Å
α=96.464(3)° β=95.779(3)° γ=99.987(4)°
9
C24H34N2O2,2(C2F3O2)
RSC Medicinal Chemistry (2020)
a=12.18020(10)Å b=16.45030(10)Å c=14.08290(10)Å
α=90° β=93.2560(10)° γ=90°
40
C23H29F3N3O2,C2F3O2,C4H10O
RSC Medicinal Chemistry (2020)
a=15.6425(3)Å b=12.7231(2)Å c=16.3931(3)Å
α=90° β=106.097(2)° γ=90°
6-methyl-2-(3-methyl-4,5,6,7-tetrahydro-2H-indazol-2-yl)pyrimidin-4(3H)-one
C13H16N4O
RSC Medicinal Chemistry (2020)
a=8.1640(3)Å b=8.5511(4)Å c=19.8770(7)Å
α=93.396(3)° β=99.154(3)° γ=117.195(4)°
2-(3-ethyl-4,5,6,7-tetrahydro-2H-indazol-2-yl)-6-methylpyrimidin-4(3H)-one
C14H18N4O
RSC Medicinal Chemistry (2020)
a=18.8002(2)Å b=9.62410(10)Å c=14.3730(2)Å
α=90° β=90° γ=90°
6-ethyl-4-hydroxy-2-(3-methyl-5-oxo-2,5-dihydro-1H-pyrazol-1-yl)pyrimidin-1-ium
Cl,C10H13N4O2,H2O
RSC Medicinal Chemistry (2020)
a=8.66205(5)Å b=14.39226(6)Å c=9.94738(4)Å
α=90° β=90.8062(4)° γ=90°